Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2009
11/10/2009US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009CA2410862C Factor viia inhibitory (thio)urea derivatives, their preparation and their use
11/10/2009CA2401637C N-(heterocyclyl)benzene- or - pyridinesulphonamides as antithrombotic and anticoagulant agents
11/10/2009CA2371213C Inhibitors of carboxypeptidase u
11/10/2009CA2320244C Method for producing aqueous polymer dispersions containing colorants
11/05/2009WO2009134224A1 Synergistic pesticidal mixtures
11/05/2009WO2009133687A1 Cyclopentylacrylic acid amide derivative
11/05/2009WO2009133576A1 A process for the preparation of 4-[2-(5-ethyl-2-pyridyl)ethoxy]nitrobenzene and pioglitazone
11/05/2009WO2009133348A1 Aminopyridine derivatives
11/05/2009WO2009132979A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009WO2009132978A1 4-dimethylaminobutyric acid derivatives
11/05/2009WO2009132453A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009WO2009132452A1 Diaryl-cyclylalkyl derivatives as calcium channel blockers
11/05/2009WO2009080203A3 Aminobenzamide derivatives as useful agents for controlling animal parasites
11/05/2009WO2009002829A3 Tableted compositions containing atazanavir
11/05/2009WO2009002826A3 Tableted compositions containing atazanavir
11/05/2009WO2009002823A3 Tableted compositions containing atazanavir
11/05/2009WO2009002821A3 Tableted compositions containing atazanavir
11/05/2009WO2008095064A3 High stability diionic liquid salts
11/05/2009US20090275752 Novel Process for Statins and its Pharmaceutically Acceptable Salts Thereof
11/05/2009US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/05/2009US20090275611 Compounds Which Modulate The CB2 Receptor
11/05/2009US20090275575 Benzophenone derivatives useful for inhibiting formation of microtubule
11/05/2009US20090275572 Fab i inhibitors
11/05/2009US20090275565 Substituted aralkyl derivatives
11/05/2009US20090275556 Aryl sulfonamides useful as inhibitors of chemokine receptor activity
11/05/2009US20090275550 2-(4-isopropenylphenyl)-N-[(1R)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide; epilepsy, pain, neuropathic pain, schizophrenia, Parkinson's disease, depression, anxiety, sleep disorders, psychosis, schizophrenia, cardiac arrhythmia and hypertension
11/05/2009US20090275537 Certain chemical entities, compositions, and methods
11/05/2009US20090275515 2-hydroxy-2-phenylthiophenylpropionamides as androgen receptor modulators
11/05/2009US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/05/2009CA2722733A1 Cyclopentylacrylamide derivative
11/05/2009CA2722704A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009CA2722648A1 Aminopyridine derivatives
11/05/2009CA2722114A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009CA2722087A1 4-dimethylaminobutyric acid derivatives
11/04/2009EP1723140B1 Process for the preparation of tryptase inhibitors
11/04/2009EP1641465B1 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
11/04/2009EP1606261B1 Novel process for the preparation of roflumilast
11/04/2009EP1553092B1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent
11/04/2009EP1473286B1 Process for producing biaryl compound
11/04/2009EP1339684B1 Mch antagonists and their use in the treatment of obesity
11/04/2009EP1253152B1 Method of converting functional group through halogen-metal exchange reaction
11/04/2009CN101573336A Chemical compounds
11/04/2009CN101573335A Kinase inhibitors
11/03/2009US7612105 3-arylphenyl sulfide derivative and insecticide and miticide
11/03/2009US7612097 Microbiocidal; cost efficiency; industrial scale
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612076 For treatment and/or prevention of diseases which are associated with the modulation of H3 receptors; obesity; N-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-C-phenyl-methanesulfonamide; C-(4-chloro-phenyl)-N-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-methanesulfonamide
11/03/2009US7612065 Fused n-heterocylic derivatives; mitogen-activated protein kinase inhibitors; Parkinson's disease
11/03/2009US7611696 Block solar radiation; applying to skin, hair
11/03/2009CA2565660C Ortho substituted aryl or heteroaryl amide compounds
11/03/2009CA2449729C Prodrugs of gaba analogs, compositions and uses thereof
11/03/2009CA2420585C Amides of r-2-(aminoaryl)-propionic acids for use in the prevention of leucocyte activation
11/03/2009CA2341291C Pyridine ketones useful as herbicides
10/2009
10/29/2009WO2009131299A1 Iridium-based light emitting compound having picolinic acid-n-oxide as auxiliary ligand and organic light emitting diode comprising the same
10/29/2009WO2009131255A1 Polymeric compound having residue of nitrogenated heterocyclic compound
10/29/2009WO2009131254A1 Composition containing nitrogenous heterocyclic compounds
10/29/2009WO2009131245A1 Iminopyridine derivatives and use thereof
10/29/2009WO2009131135A1 Iminopyridine derivative and use thereof
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130873A1 Hydroalkane sulfonate and use thereof
10/29/2009WO2009130534A1 Process for synthesizing atazanavir
10/29/2009WO2009130422A2 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
10/29/2009WO2009129726A1 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture
10/29/2009WO2009129573A1 Nicotinamide derivatives
10/29/2009WO2009101201A3 Mixtures of metal hydrides and ionic liquids and uses of such mixtures
10/29/2009US20090270631 Therapeutic agent for diabetes
10/29/2009US20090270627 4-Ethynyl (1,2-dicyanobenzene)-4'-Ethynylphenyl-1(4,5-dicyanobenzene); 1,4-Bis(4-pyridyl)butadiyne; 4-ethynyl(pyridine)-4'-ethynylnaphthalene-1-pyridine; self-assembled mono-, multilayers/ supramolecular objects; three-terminal devices; logic switches;nanoelectronic ; computers; wires; dielectrics
10/29/2009US20090270616 Aryl sulfonamides
10/29/2009US20090270499 Process for Synthesizing Atazanavir
10/29/2009US20090270423 Antibacterial small molecules and methods for their synthesis
10/29/2009US20090270399 Novel pyridazine derivatives and medicines containing the same as effective ingredients
10/29/2009US20090270393 Iminopyridine Derivatives and Use Thereof
10/29/2009US20090270382 Soluble epoxide hydrolase inhibitors
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090270360 Dicarboxamide derivatives
10/29/2009US20090270338 Diaryl-cyclylalkyl derivatives as calcium channel blockers
10/29/2009US20090270248 Basic ionic liquids
10/29/2009US20090269855 Methods and compositions for mass spectrometry analysis
10/29/2009CA2753532A1 Nicotinamide derivatives
10/29/2009CA2723216A1 Iminopyridine derivatives and use thereof
10/29/2009CA2722258A1 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2722031A1 Iminopyridine derivative and use thereof
10/28/2009EP2111399A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
10/28/2009EP2111393A2 Process for the synthesis of diaminopyridines from glutaronitriles
10/28/2009EP2111223A1 Amine derivative compounds for treating ophthalmic diseases and disorders
10/28/2009EP1973881B1 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides
10/28/2009EP1692098B1 Alpha-ketoamide derivative, and production method and use thereof
10/28/2009EP1631548B1 Inhibitors of akt activity
10/28/2009EP1210331B1 Process for the preparation of 2-cyanopyridines
10/28/2009CN101568523A Novel intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
10/28/2009CN101565409A Piperazidine or homopiperazine oxalyl hydrazine class compound, preparation and use thereof
10/28/2009CN101565401A Granular niacin production method by extrusion and granulation
10/28/2009CN101565400A Preparation method of 4-amino-3, 5, 6-chloropyridine-2-methanoic acid
10/28/2009CN101565399A Method for synthesizing 2-chloro-3-amino-4-methylpyridine by ethyl cyanoacetate and acetone
10/28/2009CN101565398A Process for preparing atazanavir bisulfate and novel forms
10/28/2009CN100554249C Insecticide for agricultural or horticultural use and method of use thereof
1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 633